Guangzhou Pharmaceuticals Company Limited Sustainability Profile
Guangzhou Pharmaceuticals Company Limited, often referred to as GPC, is a leading player in the pharmaceutical industry, headquartered in Guangzhou, China. Established in 1997, GPC has made significant strides in the development and distribution of a wide range of pharmaceutical products, including traditional Chinese medicine, chemical drugs, and health supplements. With a strong operational presence across various regions in China and beyond, GPC is renowned for its commitment to quality and innovation. The company’s core offerings, which include both prescription and over-the-counter medications, are distinguished by their adherence to rigorous safety standards and advanced research methodologies. Recognised for its market leadership, Guangzhou Pharmaceuticals has achieved notable milestones, positioning itself as a trusted name in healthcare solutions. Its dedication to enhancing public health through effective and accessible products underscores its pivotal role in the pharmaceutical landscape.
DitchCarbon Score
How does Guangzhou Pharmaceuticals Company Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Guangzhou Pharmaceuticals Company Limited's score of 22 is lower than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Guangzhou Pharmaceuticals Company Limited, headquartered in China (CN), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, which may influence its climate-related initiatives and reporting. As of now, there are no documented reduction targets or climate pledges from Guangzhou Pharmaceuticals Company Limited. The lack of specific emissions data and reduction initiatives suggests that the company may still be in the early stages of formalising its climate commitments. Given the context of the pharmaceutical industry, it is essential for companies like Guangzhou Pharmaceuticals to establish clear carbon reduction strategies and align with industry standards, such as those set by the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). The cascading of data from Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited may provide future insights into emissions performance and climate commitments. In summary, while Guangzhou Pharmaceuticals Company Limited currently lacks specific emissions data and reduction targets, its affiliation with a larger corporate entity may play a role in shaping its future climate strategies.
How Carbon Intensive is Guangzhou Pharmaceuticals Company Limited's Industry?
How Carbon Intensive is Guangzhou Pharmaceuticals Company Limited's Location?
Guangzhou Pharmaceuticals Company Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Guangzhou Pharmaceuticals Company Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
